8Q7P
| |
8QCR
| |
8Q99
| |
8Q9H
| |
8Q97
| |
8Q9D
| |
8Q98
| |
8Q8L
| |
8Q8F
| |
8Q8U
| |
8Q8W
| |
8Q9C
| |
8Q8Y
| |
8Q9E
| |
8Q8Z
| |
8Q9A
| |
8Q8E
| |
8Q8X
| |
8Q9B
| |
8QJJ
| CTE type II (tau intermediate amyloid) | Descriptor: | Isoform Tau-D of Microtubule-associated protein tau | Authors: | Lovestam, S, Scheres, S.H.W. | Deposit date: | 2023-09-13 | Release date: | 2023-10-18 | Last modified: | 2024-01-17 | Method: | ELECTRON MICROSCOPY (3.35 Å) | Cite: | Disease-specific tau filaments assemble via polymorphic intermediates. Nature, 625, 2024
|
|
6UQU
| |
6UR3
| |
4JZR
| Structure of Prolyl Hydroxylase Domain-containing Protein (PHD) with Inhibitors | Descriptor: | 1,2-ETHANEDIOL, 2-(biphenyl-4-yl)-8-[(1-methyl-1H-imidazol-2-yl)methyl]-2,8-diazaspiro[4.5]decan-1-one, Egl nine homolog 1, ... | Authors: | Ma, Y, Yang, L. | Deposit date: | 2013-04-03 | Release date: | 2013-10-30 | Last modified: | 2024-10-16 | Method: | X-RAY DIFFRACTION (2.1 Å) | Cite: | Novel complex crystal structure of prolyl hydroxylase domain-containing protein 2 (PHD2): 2,8-Diazaspiro[4.5]decan-1-ones as potent, orally bioavailable PHD2 inhibitors Bioorg.Med.Chem., 21, 2013
|
|
1YL8
| 3D Solution Structure of [Tyr3]Octreotate derivatives in DMSO | Descriptor: | [Tyr3]Octreotate peptide | Authors: | Spyroulias, G.A, Galanis, A.S, Petrou, C, Vahliotis, D, Sotiriou, P, Nikolopoulou, A, Nock, B, Maina, T, Cordopatis, P. | Deposit date: | 2005-01-19 | Release date: | 2005-09-20 | Last modified: | 2023-11-15 | Method: | SOLUTION NMR | Cite: | 3D solution structure of [Tyr3]octreotate derivatives in DMSO: structure differentiation of peptide core due to chelate group attachment and biologically active conformation. Med.Chem., 1, 2005
|
|
1YL9
| 3D Solution Structure of [Tyr3]Octreotate derivatives in DMSO | Descriptor: | 3-[(2-AMINOETHYL)AMINO]-2-{[(2-AMINOETHYL)AMINO]METHYL}PROPANAL, [Tyr3]Octreotate | Authors: | Spyroulias, G.A, Galanis, A.S, Petrou, C, Vahliotis, D, Sotiriou, P, Nikolopoulou, A, Nock, B, Maina, T, Cordopatis, P. | Deposit date: | 2005-01-19 | Release date: | 2005-09-20 | Last modified: | 2022-03-02 | Method: | SOLUTION NMR | Cite: | 3D solution structure of [Tyr3]octreotate derivatives in DMSO: structure differentiation of peptide core due to chelate group attachment and biologically active conformation. Med.Chem., 1, 2005
|
|